Effect of growth hormone and glutamine on the short bowel: five years later

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.

Gut·2005

Treatment of short-bowel syndrome.

Current opinion in clinical nutrition and metabolic care·2001

Rational approach to patients with unintentional weight loss.

Mayo Clinic proceedings·2001

Metastasis of head and neck carcinoma to the site of percutaneous endoscopic gastrostomy: case report and literature review.

JPEN. Journal of parenteral and enteral nutrition·2001

Prophylactic placement of gastrostomy feeding tubes before radiotherapy in patients with head and neck cancer: is it worthwhile?

Journal of clinical gastroenterology·2001

Effect of glutamine in short-bowel syndrome.

Clinical nutrition (Edinburgh, Scotland)·2001

Impact of non-enteric-coated pancreatic enzyme replacement therapy (NEPERT) on pain in patients with chronic pancreatitis: a double-blind, parallel-group, placebo-controlled, randomised trial.

Gut·2026

HBV induces immunosuppressive macrophages via metabolic and epigenetic reprogramming to facilitate the establishment of chronic persistent infection.

Gut·2026

Longitudinal gut microbiome dynamics during immunotherapy identify microbial features of clinical benefit in advanced primary liver cancer.

Gut·2026

Divergent microbial preludes to necrotising enterocolitis defined by gut phages and bacterial resistomes.

Gut·2026

Patient-level predictors of safety and recurrence after cold versus hot snare resection of large, non-pedunculated colorectal polyps: an individual patient data meta-analysis of four randomised-controlled trials.

Gut·2026

NCACC maps cross-sample spatial niches and reveals cIgG+ epithelial rare cells driving liver cancer invasion.

Gut·2026

Gut microbiota: a novel key player in urinary stone formation - from oxalate metabolism to systemic regulation.

Gut microbes·2026

Added Value of Quadriceps Muscle Layer Thickness to modified Nutrition Risk in the Critically Ill (mNUTRIC) Score in Predicting Clinical Outcomes in Critically Ill Patients: A Prospective Observational Study.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2026

Diabetes-associated Alterations in the Gut Microbiota-metabolite Profile of NAFLD Under Complex Clinical Conditions.

Journal of clinical and experimental hepatology·2026

Gut microbiota-host adaptive immune interactions in type 2 diabetes mellitus: mechanisms, disease progression, and microbiota-based therapeutic strategies.

Frontiers in microbiology·2026

Integrative multi-omics analysis prioritizes compartment-specific candidate targets of gut microbiota metabolites in diabetic kidney disease.

Frontiers in immunology·2026

Nutriments: Integrating Patient-Centered Nutrition Education for Medical Students within a Clinical Presentation Framework.

Medical science educator·2026

Related Experiment Videos

Effect of growth hormone and glutamine on the short bowel: five years later

Related Concept Videos

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.

Treatment of short-bowel syndrome.

Rational approach to patients with unintentional weight loss.

Metastasis of head and neck carcinoma to the site of percutaneous endoscopic gastrostomy: case report and literature review.

Prophylactic placement of gastrostomy feeding tubes before radiotherapy in patients with head and neck cancer: is it worthwhile?

Effect of glutamine in short-bowel syndrome.

Impact of non-enteric-coated pancreatic enzyme replacement therapy (NEPERT) on pain in patients with chronic pancreatitis: a double-blind, parallel-group, placebo-controlled, randomised trial.

HBV induces immunosuppressive macrophages via metabolic and epigenetic reprogramming to facilitate the establishment of chronic persistent infection.

Longitudinal gut microbiome dynamics during immunotherapy identify microbial features of clinical benefit in advanced primary liver cancer.

Divergent microbial preludes to necrotising enterocolitis defined by gut phages and bacterial resistomes.

Patient-level predictors of safety and recurrence after cold versus hot snare resection of large, non-pedunculated colorectal polyps: an individual patient data meta-analysis of four randomised-controlled trials.

NCACC maps cross-sample spatial niches and reveals cIgG+ epithelial rare cells driving liver cancer invasion.

Gut microbiota: a novel key player in urinary stone formation - from oxalate metabolism to systemic regulation.

Added Value of Quadriceps Muscle Layer Thickness to modified Nutrition Risk in the Critically Ill (mNUTRIC) Score in Predicting Clinical Outcomes in Critically Ill Patients: A Prospective Observational Study.

Diabetes-associated Alterations in the Gut Microbiota-metabolite Profile of NAFLD Under Complex Clinical Conditions.

Gut microbiota-host adaptive immune interactions in type 2 diabetes mellitus: mechanisms, disease progression, and microbiota-based therapeutic strategies.

Integrative multi-omics analysis prioritizes compartment-specific candidate targets of gut microbiota metabolites in diabetic kidney disease.

Nutriments: Integrating Patient-Centered Nutrition Education for Medical Students within a Clinical Presentation Framework.

Related Experiment Videos

Effect of growth hormone and glutamine on the short bowel: five years later

Related Concept Videos

Related Articles